Role of gender, smoking profile, hypertension, and diabetes on saphenous vein and internal mammary artery endothelial relaxation in patients with coronary artery bypass grafting

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 3, 2010, Pages 199-205

  Muir, Andrew Duncan ^a   McKeown, Pascal Patrick ^a   Bayraktutan, Ulvi ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Coronary artery bypass grafting; Endothelial dys function; Internal mammary artery; Risk factors; Saphenous vein

Indexed keywords

CORONARY ARTERY BYPASS GRAFTING; ENDOTHELIAL DYS/FUNCTION; INTERNAL MAMMARY ARTERY; RISK FACTORS; SAPHENOUS VEIN;

HEART; SELF ASSEMBLY;

GRAFTING (CHEMICAL);

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; POTASSIUM CHANNEL STIMULATING AGENT; STATIN;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SAPHENOUS VEIN; SEX DIFFERENCE; SMOKING; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY BYPASS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MAMMARY ARTERIES; MIDDLE AGED; SAPHENOUS VEIN; SEX FACTORS; SMOKING; VASODILATION;

EID: 77956491616     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.3.11757     Document Type: Article

References (50)

1. Taggart DP. Surgery is the best intervention for severe coronary disease. Br Med J 2005; 330:785-6.
2. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314:1-6.
3. Endo M, Tomizawa Y, Nishida H. Bilateral versus unilateral internal mammary revascularisation in patients with diabetes. Circulation 2002; 108:1343-9.
4. Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004; 78:2005-14.
5. Pompilio G, Rossoni G, Alamanni F, Tartara P, Barajon I, Rumio C, et al. Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolaemic and diabetic patients. Ann Thorac Surg 2001; 72:1290-7.
6. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A. Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25:475-80.
7. Bayraktutan U. Free radicals, diabetes and endothelial dysfunction. Diabet Obes Metabol 2002; 4:224-38.
8. Hamilton CA, Berg G, McIntyre M, McPhaden AR, Reid JL, Dominiczak AF. Effects of nitric oxide and superoxide on relaxation in human artery and vein. Atherosclerosis 1997; 133:77-86.
9. Cable DG, Caccitolo JA, Pfeifer EA, Daly RC, Dearani JA, Mullany CJ, et al. Endothelial regulation of vascular contraction in radial and internal mammary arteries. Ann Thorac Surg 1999; 67:1083-90.
10. Berry B, Hamilton CA, Brosnan J, Magill FG, Berg GA, McMurray JJV, et al. Investigation into the sources of superoxide in human blood vessels. Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101:2206-12.
11. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002; 40:755-62.
12. Guzik TJ, Sadowski J, Kapelak B, Jopek A, Rudzinski P, Pillai R, et al. Systemic regulation of vascular NAD(P) H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol 2004; 24:1614-20.
13. Nechmad A, Merin G, Schwalb H, Shimon DV, Borman JB, Milgalter E, et al. Estrogen induces nitric oxide-mediated vasodilation of human mammary arteries in vitro. Nitric Oxide 1998; 2:460-6.
14. Wendler O, Landwehr P, Bandner-Risch D, Georg T, Schäfers H-J. Vasoreactivity of arterial grafts in the patient with diabetes mellitus: investigations on internal thoracic artery and radial artery conduits. Eur J Cardiothoracic Surg 2001; 20:305-11.
15. Barua RS, Ambrose JA, Eales-Reynolds L, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001; 104:1905-10.
16. Yang ZW, Zheng T, Zhang A, Altura BT, Altura BM. Mechanisms of hydrogen peroxide-induced contraction of rat aorta. Eur J Pharmacol 1998; 344:169-81.
17. 2+ and other cellular metabolites. Gen Pharmacol 1999; 33:325-36.
18. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-6.
19. Ignarro LJ, Buga GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9.
20. Landmesser U, Hornig B, Drexler H. Endothelial function. A critical determinant in atherosclerosis? Circulation 2004; 109:27-33.
21. Luscher TF, Diederich D, Siebenman R, Lehmann K, Stulz P, von Segesser L, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Eng J Med 1988; 319:462-7.
22. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-906.
23. Demirci B, McKeown PP, Bayraktutan U. The bimodal regulation of vascular function by superoxide anion: role of endothelium. BMB reports 2008; 41:223-9.
24. Hassan A, Chiasson M, Buth K, Hirsch G. Women have worse long-term outcomes after coronary artery bypass grafting than men. Can J Cardiol 2005; 21:757-62.
25. Stefano GB, Prevot V, Beauvilain J-C, Cadet P, Fimiani C, Welters I, et al. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 2000; 101:1594-7.
26. Huraux C, Makita T, Kurz S, Yamaguchi K, Szlam F, Tarpey MM, et al. Superoxide production, risk factors and endothelium-dependent relaxations in human internal mammary arteries. Circulation 1999; 99:53-9.
27. Akar F, Manavbasi Y, Parlar AI, Ulus AT, Katircioglu SF. The gender differences in the relaxation to levosimendan of human internal mammary artery. Cardiovasc Drugs Ther 2007; 31:331-8.
28. Figtree GA, Guzik T, Robinson BG, Channon KM, Watkins H. Functional estrogen receptor alpha promoter polymorphism is associated with improved endothelial-dependent vasodilation. Int J Cardiol 2009; In press.
29. Deja MA, Golbs KS, Wos S, Mrozek R, Bachowski R, Biernat J. Internal mammary artery graft function is not affected in hypertensive patients on therapy. Cardiovasc Surg 1997; 5:367-75.
30. Turoni CM, de Bruno MP, Coviello A, Marañón RO, Herrera RN, Muntaner J, et al. Internal mammary artery grafts reactivity in hypertensive patients: role of stretching in extraendothelial nitric oxide. Clin Exp Hypertens 2007; 29:327-44.
31. Yang Z, von Segesser L, Bauer E, Stulz P, Turina M, Lüscher TF. Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res 1991; 68:52-60.
32. Cracowski J-L, Stanke-Labesque F, Sessa C, Hunt M, Chavanon O, Devillier P, et al. Functional comparison of the human isolated femoral artery, mammary artery, gastroepiploic artery and saphenous vein. Can J Physiol Pharmacol 1999; 77:770-6.
33. Shapira OM, Xu A, Aldea GS, Vita JA, Shemin RJ, Keaney JF. Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with internal mammary artery or saphenous vein. Circulation 1999; 100:322-7.
34. Sogo N, Campanella C, Webb DJ, Megson IL. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery; therapeutic potential in bypass surgery. Br J Pharmacol 2000; 131:1236-44.
35. + channels on nitroglycerin-mediated vasorelaxation in humans. Eur J Pharmacol 2002; 446:145-50.
36. Al-Benna S, Hamilton CA, McClure JD, Rogers PN, Berg GA, Ford I, et al. Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26:218-23.
37. Ghosh M, Wang HD, McNeill JR. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br J Pharmacol 2004; 141:562-73.
38. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension. Role of the endothelium. Hypertension 1999; 33:1353-8.
39. Chello M, Spadaccio C, Lusini M, Covino E, Blarzino C, De Marco F, et al. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure. Diabetes Metab Res Rev 2009; 25:420-6.
40. Chatterjee A, Catravas JD. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc Pharmacol 2008; 49:134-40.
41. Kunadian B, Dunning J, Millner RWJ. Modifiable risk factors remain significant causes of medium term mortality after first time coronary artery bypass grafting. J Cardiothorac Surg 2007; 2:51.
42. Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, et al. and the Post-CABG Trial Investigators. Prognostic factors for atherosclerosis progression in saphenous vein grafts. The postcoronary artery bypass graft (Post-CABG) Trial. J Am Coll Cardiol 2000; 36:1877-83.
43. Lindsay GM, Tolmie EP, Martin WM, Hutton IM, Belcher PR. Smoking after coronary artery bypass: high three-year mortality. Thorac Cardiovasc Surg 2009; 57:135-40.
44. Guthikonda S, Sinkey CA, Haynes WG. What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arterioscler Thromb Vasc Biol 2007; 27:1172-6.
45. Edvinsson ML, Anderson SE, Xu CB, Edvinsson L. Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation. Vasc Health Risk Manag 2008; 4:699-704.
46. Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez-Gallerani AS. Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels. J Surg Res 1999; 82:43-7.
47. Sbajdar RM, Busuttil SJ, Averbook A, Graham DJ. Inhibition of endothelial cell migration by cigarette smoke condensate. J Surg Res 2001; 96:10-6.
48. Michaud SE, Dussault S, Groleau J, Haddad P, Rivard A. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. J Mol Cell Cardiol 2006; 41:275-84.
49. Canham PB, Finlay HM, Boughner DR. Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels. Cardiovasc Res 1997; 34:557-67.
50. Muir AD, McKeown PP, Bayraktutan U. The role of oxidative stress in modulation of the relaxant responses of saphenous vein and internal mammary artery. Open Circ Vascu J 2010; In press.